Prio Wealth Limited Partnership’s GSK GSK Stock Holding History

Prio Wealth Limited Partnership’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,777	Closed	-$206K	–	250
2022 Q2	$206K	Hold	3,777	–	–	0.01%	246
2022 Q1	$206K	Buy	3,777 +60	+2%	+$3.26K	0.01%	258
2021 Q4	$205K	Buy	+3,717	New	+$193K	0.01%	266
2020 Q4	–	Sell	-4,677	Closed	-$220K	–	277
2020 Q3	$220K	Hold	4,677	–	–	0.01%	249
2020 Q2	$238K	Buy	+4,677	New	+$240K	0.01%	232
2017 Q4	–	Sell	-4,628	Closed	-$234K	–	236
2017 Q3	$234K	Hold	4,628	–	–	0.01%	221
2017 Q2	$249K	Buy	4,628 +213	+5%	+$11.4K	0.01%	213
2017 Q1	$232K	Sell	4,415 -560	-11%	-$28.4K	0.01%	220
2016 Q4	$239K	Sell	4,975 -640	-11%	-$31.6K	0.01%	222
2016 Q3	$302K	Hold	5,615	–	–	0.02%	214
2016 Q2	$304K	Hold	5,615	–	–	0.02%	208
2016 Q1	$284K	Sell	5,615 -363	-6%	-$18.1K	0.02%	215
2015 Q4	$301K	Sell	5,978 -480	-7%	-$24.5K	0.02%	212
2015 Q3	$310K	Sell	6,458 -160	-2%	-$8.33K	0.02%	209
2015 Q2	$344K	Hold	6,618	–	–	0.02%	206
2015 Q1	$381K	Hold	6,618	–	–	0.02%	198
2014 Q4	$353K	Sell	6,618 -12	-0.2%	-$671	0.02%	202
2014 Q3	$380K	Hold	6,630	–	–	0.02%	193
2014 Q2	$443K	Buy	6,630 +12	+0.2%	+$812	0.02%	183
2014 Q1	$442K	Hold	6,618	–	–	0.02%	182
2013 Q4	$441K	Hold	6,618	–	–	0.02%	184
2013 Q3	$415K	Hold	6,618	–	–	0.02%	185
2013 Q2	$413K	Buy	+6,618	New	+$420K	0.02%	179

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Prio Wealth Limited Partnership's GSK Position: Q3 2022 in Review

Prio Wealth Limited Partnership sold out of GSK (GSK) in Q3 2022, closing a stake of 3,777 shares — an estimated $206K sold.

Prio Wealth Limited Partnership first reported a position in GSK in Q2 2013 and held it in 23 quarters. The position peaked at $443K in Q2 2014. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Prio Wealth Limited Partnership reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Prio Wealth Limited Partnership sold 3,777 GSK shares in Q3 2022, an estimated $206K.
Prio Wealth Limited Partnership first reported a position in GSK in Q2 2013 and held it in 23 quarters.
Prio Wealth Limited Partnership's GSK position peaked at $443K in Q2 2014.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2022, filed 27 Feb 2023.